Dr. Tipple is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Oklahoma Children's Hospital OU Health
1200 North Children's Ave., ETNP7504
Oklahoma City, OK 73104Phone+1 405-271-5215Fax+1 405-271-1236
Summary
- I am the Section Chief of Neonatal-Perinatal Medicine for the OU College of Medicine Department of Pediatrics.
Most recently I served as director of the Neonatal Redox Biology Laboratory at the University of Alabama in Birmingham, as associate director of the Neonatal-Perinatal Fellowship Program and physician lead for Family Centered Care Initiative in the Regional Newborn Intensive Care Unit.
Originally from rural Wabash County, Indiana, I earned my medical degree at Indiana University School of Medicine and then completed a residency in general pediatrics and fellowship in neonatal-perinatal medicine at Nationwide Children’s Hospital, Columbus, Ohio.
I have a special interest in redox biology, lung development and lung injury/repair with a long history of grant funding from the National Institutes of Health. Additionally, I am active in many national and international boards and committees, including the National Institutes of Health, National Kidney Foundation of America and United Network for Organ Sharing.
Education & Training
- Nationwide Children's Hospital/Ohio State UniversityFellowship, Neonatal-Perinatal Medicine, 2003 - 2006
- Nationwide Children's Hospital/Ohio State UniversityResidency, Pediatrics, 2000 - 2003
- Indiana University School of MedicineClass of 2000
- Butler UniversityBachelor's, 1991 - 1995
Certifications & Licensure
- OK State Medical License 2019 - 2025
- AL State Medical License 2014 - 2019
- OH State Medical License 2000 - 2015
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Neonatal-Perinatal Medicine
Awards, Honors, & Recognition
- Cassady Presidential Young Investigator Award Perinatal Research Society Annual Meeting, 2013
- Recognition Award for Outstanding Early Career Investigators American Thoracic Society Foundation, 2013
- Young Investigator Award Society for Free Radical Biology and Medicine Annual Meeting, 2004-2005
- Join now to see all
Publications & Presentations
PubMed
- 45 citationsDifferential responses in the lungs of newborn mouse pups exposed to 85% or >95% oxygen.Lynette K. Rogers, Trent E. Tipple, Leif D. Nelin, Stephen E. Welty
Pediatric Research. 2009-01-01 - 17 citationsThioredoxin Reductase-1 Inhibition Augments Endogenous Glutathione-Dependent Antioxidant Responses in Experimental Bronchopulmonary Dysplasia.Stephanie B. Wall, Rachael Wood, Katelyn Dunigan, Qian Li, Rui Li
Oxidative Medicine and Cellular Longevity. 2019-01-21 - 32 citationsThe thioredoxin reductase-1 inhibitor aurothioglucose attenuates lung injury and improves survival in a murine model of acute respiratory distress syndrome.Rodney D. Britt, Markus Velten, Morgan L. Locy, Lynette K. Rogers, Trent E. Tipple
Antioxidants & Redox Signaling. 2014-06-10
Journal Articles
- microRNA-17~92 Cluster Expression is Significantly Attenuated in Bronchopulmonary DysplasiaRogers LK, Robbins M, Dukhlallah D, Yang Z, Lee LJ, Mikhail M, Nuovo G, Pryhuber GS, McGwin G, Marsh CB, AnnalsATS, 1/1/2015
- DHA Suppresses Chronic Apoptosis in the Lung Caused by Perinatal InflammationAli M, Heyob KM, Velten M, Rogers, LK, American Journal of Physiology: Lung Cellular and Molecular Physiology, 1/1/2015
- The Thioredoxin System in Neonatal Lung DiseaseTipple TE, Antioxidants and Redox Signaling, 1/1/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Decreased Plasma miR-17~92 Cluster Expression in the First Week of Life Correlates with a Subsequent Diagnosis of Bronchopulmonary DysplasiaYang Z, Lee LJ, McGwin G, Rogers LK, American Journal of Respiratory and Critical Care Medicine, 1/1/2015
- Thioredoxin Reductase Inhibition Attenuates Hyperoxia-induced Lung Developmental Deficits in Newborn MiceHill CL, Pierce DL, Velten M, Rogers LK, American Journal of Respiratory and Critical Care Medicine, 1/1/2014
- Haplotype-Insufficiency of miR-17~92 Cluster Alters Lung Development in Newborn MiceRobbins ME, Rogers LK, Piper MG, Pediatric Academic Societies, 1/1/2014
- Join now to see all
Lectures
- Targeting Thioredoxin Reductase to Prevent Oxygen-Induced Lung InjuryUniversity of Alabama at Birmingham - 1/1/2015
- Thioredoxin Reductase Inhibition to Prevent Lung Injury: Interplay With Cadmium and SeleniumEmory University, Atlanta, GA - 1/1/2015
- Thioredoxin Reductase: A Novel Therapeutic Target to Prevent Oxidant Lung InjurySanford Research Institute, Sioux Falls, SD - 1/1/2015
- Join now to see all
Press Mentions
- Oklahoma Children's Hospital Doctors to Hold Virtual Event to Give Parents Information on COVID-19August 12th, 2021
Grant Support
- Targeting Thioredoxin Reductase-1 to Prevent Bronchopulmonary DysplasiaNational Heart Lung Blood Institute2014–Present
- Regulation Of Lung Growth And Development By Thioredoxin Interacting ProteinNational Heart, Lung, And Blood Institute2010–2012
Professional Memberships
- Fellow
- Member
- Perinatal Research SocietyMember
- Society For Free Radical Biology and MedicineMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: